What is Hypertension Diagnostics Inc?
designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally.
HDII · Verdict
Limited reward · low risk
HDII stands out on balance sheet and volatility, but watch the profitability signal.
Based on 63% data coverage
HDII · Verdict
Top decile vs peers
Above average
0% return on equity
Below average
Model-based scoring. For information only — not financial advice.
designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company is listed on the PINK in USA, operating in the Financial Services sector, with a market capitalisation of 28.48K.
The scoring profile indicates weak reward characteristics across most factors, including growth and momentum. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.